Invesaro

Stocks Health care SIBN

NASDAQ · Health care

SI-BONE, Inc. (SIBN)

SI-BONE, Inc. brought in $213.6M of revenue over the twelve months to June 30, 2026, up 15.3% from a year earlier. It posted a net loss of $14.6M. In fiscal 2025 capital spending exceeded operating cash flow by $9.1M. At June 30, 2026 it held $33.1M in cash against $35.6M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 4, 2026.

Price
$18.59
+0.38% on the day · September 25, 2026
52-week range $11.48 to $21.89
Market cap
$833.2M
Revenue (last 12 months)
$213.6M
+15.3% year on year
Net margin
-6.9%

What SI-BONE, Inc. does

SI-BONE, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker SIBN.

Revenue and profit by year

Revenue
FY18: $55.4M $55.4M FY18FY19: $67.3M $67.3M FY19FY20: $73.4M $73.4M FY20FY21: $90.2M $90.2M FY21FY22: $106.4M $106.4M FY22FY23: $138.9M $138.9M FY23FY24: $167.2M $167.2M FY24FY25: $200.9M $200.9M FY25
Net income
FY18: -$17.5M -$17.5M FY18FY19: -$38.4M -$38.4M FY19FY20: -$43.7M -$43.7M FY20FY21: -$56.6M -$56.6M FY21FY22: -$61.3M -$61.3M FY22FY23: -$43.3M -$43.3M FY23FY24: -$30.9M -$30.9M FY24FY25: -$18.9M -$18.9M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$200.9M-$22.3M-$18.9M-$0.44-$9.1M
2024$167.2M-$35.2M-$30.9M-$0.75-$22.9M
2023$138.9M-$46.9M-$43.3M-$1.13-$26.5M
2022$106.4M-$59.6M-$61.3M-$1.79-$51.2M
2021$90.2M-$51.7M-$56.6M-$1.71-$45.9M
2020$73.4M-$38.6M-$43.7M-$1.50-$33.2M

Latest SEC filings

What SI-BONE, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 11, 2026
  2. August 14, 2026
  3. August 4, 2026
    Quarterly report 10-Q · period to June 30, 2026
  4. August 3, 2026
  5. July 30, 2026
  6. June 8, 2026
  7. May 11, 2026
    Quarterly report 10-Q · period to March 31, 2026
  8. May 11, 2026
  9. May 7, 2026
  10. April 24, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 3, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about SIBN

What does SI-BONE, Inc. do?

SI-BONE, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker SIBN.

Is SI-BONE, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $14.6M on revenue of $213.6M.

How much revenue does SI-BONE, Inc. make?

Over the twelve months to June 30, 2026 SI-BONE, Inc. reported revenue of $213.6M. That is 15.3% more than a year earlier.

When did SI-BONE, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 4, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the material agreement from September 11, 2026.

Similar companies

Follow SIBN

Get an email when SI-BONE, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow SIBN: get an email when it files

Where the numbers come from

Financial figures are the values SI-BONE, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.